Newer Epilepsy Meds Safe During Pregnancy, Won't Affect Kids' Neurodevelopment

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 2, 2024.

By Ernie Mundell HealthDay Reporter

MONDAY, Dec. 2, 2024 -- For decades, it's been known that certain older medications women use to control epilepsy seizures can pose risks to a fetus.

However, data now suggests that no such risk exists for newer-generation anti-seizure meds.

“We need to balance making sure there is enough medicine on board to protect the mother and her developing fetus from seizures, but not too much where we're creating risk for the child,” explained study co-lead investigator Dr. Kimford Meador, a professor of neurology at Stanford University.

Older medications such as valproate have been strongly linked to birth defects and cognitive issues in offspring. So, women with epilepsy have long been warned to stay off of these drugs while pregnant.

However, seizure control is important, since seizures can also pose risks to the fetus and mother-to-be.

New anti-seizure medications have been developed -- but do they pose any risk to the fetus?

To find out, Meador's team tracked the language development of 387 children. Kids were tracked up to the age of 6.

Of those, 298 had been born to women with epilepsy who took newer antiseizure medications while pregnant -- typically lamotrigine, levetiracetam or a combination of both drugs.

"Children were tested on a variety of verbal abilities, including vocabulary and matching spoken words to pictures," according to a news release from the National Institute of Neurological Disorders and Stroke (NINDS), which funded the study.

The result: No difference in language scores between kids exposed to the drugs in the womb and those who were not exposed.

“What makes this study meaningful is that when you assess a child at 6, the tests are a lot more sensitive than at earlier ages, especially 2-year-olds," Meador noted in the news release. "There’s measurable impact on school performance and results are more predictive of adult cognitive ability."

The new findings should reassure parents, since prior studies that had followed kids only up to age 2 or 3 had suggested that fetal exposure to high doses of levetiracetam might impair a child's cognitive skills.

However, by 6 years of age, no differences were found, according to the new research.

“Controlling seizures during pregnancy is an important part of prenatal care for women with epilepsy, but for years, the effects of newer antiseizure medications on their children was unknown,” noted Dr. Adam Hartman, program director at NINDS.

“One major component of this study was correlating the cognitive abilities of children with maternal blood levels of the drugs. This opens the door to future work and might inform better dosing strategies," said Hartman, who wasn't involved in the study.

Sources

  • National Institute of Neurological Disorders and Stroke, news release, Nov. 27, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-12-03 12:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords